Entrada Therapeutics, Inc.
TRDA나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
1건
최근 2026.10.14
90일 내부자 순매수
-53억 3,615만원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 10건
- US미국주요사항·수시공시중요도 낮음2026.10.148-K · Current report (Items 7.01, 8.01, 9.01)
Entrada Therapeutics, Inc.TRDA
8-K · 2026.10.14 20:52 KST
- US미국대량보유(5%)중요도 보통2026.09.10정정SCHEDULE 13D/A · Beneficial ownership report (13D)
Entrada Therapeutics, Inc.TRDA
SCHEDULE 13D/A · 2026.09.10
- US미국임원·주요주주 소유중요도 높음2026.09.094 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.09
- US미국임원·주요주주 소유중요도 높음2026.09.094 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.09
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Entrada Therapeutics, Inc.TRDA
Form 4 · 2026.09.03